JAPANESE ENCEPHALITIS VIRUS
|
Structure
& Property |
Transmission |
Pathogenesis |
Clinical
findings |
Laboratory
diagnosis |
Treatment |
|
Family: flavivirus Genome: single-strand RNA, +ve polarity. Size: 40-50nm Icosahedral nucleocapsid. Enveloped virion One serotype Antigenically related to dengue viruses |
Transmitted to humans by certain species of Culex mosquito endemic to Asian rice fields. Two main reservoir hosts: humans and pigs. |
Infection follows bite by infected mosquito. Virus replicates locally either in skin, lymphatics or endothelium of blood vessels. Transient viraemia. Virus enters nervous system: - by capillary seeding through endothelium into meninges and brain. - infection of nerve endings with subsequent axoplasmic transport to neurons. Destruction of neurons & glial cells, perivascular inflitration with lymphocytes, focal hemorrhages. |
Most common cause of epidemic encephalitis. Abrupt onset with fever, headache, malaise, drowsiness, vomiting & generalized convulsions. Marked and increasing disturbances of sensorium & signs of meningeal irritation. CSF abnormalities: pleocytosis, elevated glucose and protein content. Mortality: - <10% in endemic areas - 20-50% in severe epidemics. Neurological sequelae: - motor weakness - mental backwardness - behavior disorders |
Diagnosis: - haemagglutiation-inhibition for rise in antibody titer. - IgM and IgG ELISA IgM produced in CNS during encephalitis, appears in CSF |
Japanese encephalitis vaccine: - inactivated virus in mouse brain - in three doses subcutaneously. - recommended for travelers to endemic areas in Far East and Southeast Asia. Pesticides to control mosquito vector. |